Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
61 hedge funds and large institutions have $285M invested in Flexion Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 7 reducing their positions, and 13 closing their positions.
371% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 7
23% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 13
6% more capital invested
Capital invested by funds: $269M → $285M (+$16M)
5% more funds holding
Funds holding: 58 → 61 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$6.31M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$4.47M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.92M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.86M |
| 5 |
Schroder Investment Management Group
London,
United Kingdom
|
+$2.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$3.67M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$3.03M |
| 3 |
IHM
Iguana Healthcare Management
New York
|
-$1.13M |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$951K |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$881K |
FLXN Hedge Fund Activity: Q2 2015 in Review
61 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q2 2015, worth a combined $285M — up 6% from $269M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new FLXN positions and 13 closed out — a net gain of 3 holders — while 33 added to existing stakes and 7 trimmed.
The largest buyer was Wasatch Advisors, opening a new position worth an estimated $6.31M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $3.67M sold.
- 61 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q2 2015, up from 58 in Q1 2015.
- Funds reported $285M of Flexion Therapeutics, Inc. stock for Q2 2015, up 6% quarter-over-quarter.
- 16 funds opened new Flexion Therapeutics, Inc. positions in Q2 2015 and 13 closed out, a net change of +3 holders.
- The largest Flexion Therapeutics, Inc. buyer in Q2 2015 was Wasatch Advisors, an estimated $6.31M added.
- The largest Flexion Therapeutics, Inc. seller in Q2 2015 was EcoR1 Capital, an estimated $3.67M sold.
Based on aggregated 13F filings for Q2 2015.